Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 45

1.

Evaluating the efficacy of an algae-based treatment to mitigate elicitation of antibiotic resistance.

Grimes KL, Dunphy LJ, Loudermilk EM, Melara AJ, Kolling GL, Papin JA, Colosi LM.

Chemosphere. 2019 Jul 20;237:124421. doi: 10.1016/j.chemosphere.2019.124421. [Epub ahead of print]

PMID:
31382196
2.

Outcomes of a Multidisciplinary Clinic in Evaluating Recurrent Clostridioides difficile Infection Patients for Fecal Microbiota Transplant: A Retrospective Cohort Analysis.

Shin JH, Chaplin AS, Hays RA, Kolling GL, Vance S, Guerrant RL, Archbald-Pannone L, Warren CA.

J Clin Med. 2019 Jul 16;8(7). pii: E1036. doi: 10.3390/jcm8071036.

3.

A simplified metabolic network reconstruction to promote understanding and development of flux balance analysis tools.

Rawls KD, Dougherty BV, Blais EM, Stancliffe E, Kolling GL, Vinnakota K, Pannala VR, Wallqvist A, Papin JA.

Comput Biol Med. 2019 Feb;105:64-71. doi: 10.1016/j.compbiomed.2018.12.010. Epub 2018 Dec 17.

4.

Amixicile Reduces Severity of Cryptosporidiosis but Does Not Have In Vitro Activity against Cryptosporidium.

Bartelt LA, Bolick DT, Kolling GL, Stebbins E, Huston CD, Guerrant RL, Hoffman PS.

Antimicrob Agents Chemother. 2018 Nov 26;62(12). pii: e00718-18. doi: 10.1128/AAC.00718-18. Print 2018 Dec.

5.

Inferring Metabolic Mechanisms of Interaction within a Defined Gut Microbiota.

Medlock GL, Carey MA, McDuffie DG, Mundy MB, Giallourou N, Swann JR, Kolling GL, Papin JA.

Cell Syst. 2018 Sep 26;7(3):245-257.e7. doi: 10.1016/j.cels.2018.08.003. Epub 2018 Sep 5.

6.

A novel mouse model of Campylobacter jejuni enteropathy and diarrhea.

Giallourou N, Medlock GL, Bolick DT, Medeiros PH, Ledwaba SE, Kolling GL, Tung K, Guerry P, Swann JR, Guerrant RL.

PLoS Pathog. 2018 May 23;14(3):e1007083. doi: 10.1371/journal.ppat.1007083. eCollection 2018 Mar.

7.

Abundant production of exopolysaccharide by EAEC strains enhances the formation of bacterial biofilms in contaminated sprouts.

Borgersen Q, Bolick DT, Kolling GL, Aijuka M, Ruiz-Perez F, Guerrant RL, Nataro JP, Santiago AE.

Gut Microbes. 2018;9(3):264-278. doi: 10.1080/19490976.2018.1429877. Epub 2018 Apr 19.

8.

Innate Immune Response and Outcome of Clostridium difficile Infection Are Dependent on Fecal Bacterial Composition in the Aged Host.

Shin JH, Gao Y, Moore JH 2nd, Bolick DT, Kolling GL, Wu M, Warren CA.

J Infect Dis. 2018 Jan 4;217(2):188-197. doi: 10.1093/infdis/jix414.

9.

Novel co-culture plate enables growth dynamic-based assessment of contact-independent microbial interactions.

Moutinho TJ Jr, Panagides JC, Biggs MB, Medlock GL, Kolling GL, Papin JA.

PLoS One. 2017 Aug 2;12(8):e0182163. doi: 10.1371/journal.pone.0182163. eCollection 2017.

10.

Cross-modulation of pathogen-specific pathways enhances malnutrition during enteric co-infection with Giardia lamblia and enteroaggregative Escherichia coli.

Bartelt LA, Bolick DT, Mayneris-Perxachs J, Kolling GL, Medlock GL, Zaenker EI, Donowitz J, Thomas-Beckett RV, Rogala A, Carroll IM, Singer SM, Papin J, Swann JR, Guerrant RL.

PLoS Pathog. 2017 Jul 27;13(7):e1006471. doi: 10.1371/journal.ppat.1006471. eCollection 2017 Jul.

11.

Increased Urinary Trimethylamine N-Oxide Following Cryptosporidium Infection and Protein Malnutrition Independent of Microbiome Effects.

Bolick DT, Mayneris-Perxachs J, Medlock GL, Kolling GL, Papin JA, Swann JR, Guerrant RL.

J Infect Dis. 2017 Jul 1;216(1):64-71. doi: 10.1093/infdis/jix234. Erratum in: J Infect Dis. 2018 Apr 23;217(10):1673.

12.

Reconciled rat and human metabolic networks for comparative toxicogenomics and biomarker predictions.

Blais EM, Rawls KD, Dougherty BV, Li ZI, Kolling GL, Ye P, Wallqvist A, Papin JA.

Nat Commun. 2017 Feb 8;8:14250. doi: 10.1038/ncomms14250.

13.

Systems-level metabolism of the altered Schaedler flora, a complete gut microbiota.

Biggs MB, Medlock GL, Moutinho TJ, Lees HJ, Swann JR, Kolling GL, Papin JA.

ISME J. 2017 Feb;11(2):426-438. doi: 10.1038/ismej.2016.130. Epub 2016 Nov 8.

14.

Protein- and zinc-deficient diets modulate the murine microbiome and metabolic phenotype.

Mayneris-Perxachs J, Bolick DT, Leng J, Medlock GL, Kolling GL, Papin JA, Swann JR, Guerrant RL.

Am J Clin Nutr. 2016 Nov;104(5):1253-1262. Epub 2016 Oct 12.

15.

Protein Malnutrition Impairs Intestinal Epithelial Cell Turnover, a Potential Mechanism of Increased Cryptosporidiosis in a Murine Model.

Liu J, Bolick DT, Kolling GL, Fu Z, Guerrant RL.

Infect Immun. 2016 Nov 18;84(12):3542-3549. Print 2016 Dec.

16.

Cryptosporidium Priming Is More Effective than Vaccine for Protection against Cryptosporidiosis in a Murine Protein Malnutrition Model.

Bartelt LA, Bolick DT, Kolling GL, Roche JK, Zaenker EI, Lara AM, Noronha FJ, Cowardin CA, Moore JH, Turner JR, Warren CA, Buck GA, Guerrant RL.

PLoS Negl Trop Dis. 2016 Jul 28;10(7):e0004820. doi: 10.1371/journal.pntd.0004820. eCollection 2016 Jul.

17.

Early-life enteric infections: relation between chronic systemic inflammation and poor cognition in children.

OriĆ” RB, Murray-Kolb LE, Scharf RJ, Pendergast LL, Lang DR, Kolling GL, Guerrant RL.

Nutr Rev. 2016 Jun;74(6):374-86. doi: 10.1093/nutrit/nuw008. Epub 2016 May 3. Review.

18.

Vancomycin Treatment Alters Humoral Immunity and Intestinal Microbiota in an Aged Mouse Model of Clostridium difficile Infection.

van Opstal E, Kolling GL, Moore JH 2nd, Coquery CM, Wade NS, Loo WM, Bolick DT, Shin JH, Erickson LD, Warren CA.

J Infect Dis. 2016 Jul 1;214(1):130-9. doi: 10.1093/infdis/jiw071. Epub 2016 Feb 24.

19.

Treatment of Clostridium difficile infection using SQ641, a capuramycin analogue, increases post-treatment survival and improves clinical measures of disease in a murine model.

Moore JH 2nd, van Opstal E, Kolling GL, Shin JH, Bogatcheva E, Nikonenko B, Einck L, Phipps AJ, Guerrant RL, Protopopova M, Warren CA.

J Antimicrob Chemother. 2016 May;71(5):1300-6. doi: 10.1093/jac/dkv479. Epub 2016 Jan 31.

20.

Correction: Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.

Moore JH, Pinheiro CC, Zaenker EI, Bolick DT, Kolling GL, van Opstal E, Noronha FJ, De Medeiros PH, Rodriguez RS, Lima AA, Guerrant RL, Warren CA.

PLoS One. 2015 Sep 15;10(9):e0137037. doi: 10.1371/journal.pone.0137037. eCollection 2015. No abstract available.

21.

Defined Nutrient Diets Alter Susceptibility to Clostridium difficile Associated Disease in a Murine Model.

Moore JH, Pinheiro CC, Zaenker EI, Bolick DT, Kolling GL, van Opstal E, Noronha FJ, De Medeiros PH, Rodriguez RS, Lima AA, Guerrant RL, Warren CA.

PLoS One. 2015 Jul 16;10(7):e0131829. doi: 10.1371/journal.pone.0131829. eCollection 2015. Erratum in: PLoS One. 2015;10(9):e0137037.

22.

Metabolic network modeling of microbial communities.

Biggs MB, Medlock GL, Kolling GL, Papin JA.

Wiley Interdiscip Rev Syst Biol Med. 2015 Sep-Oct;7(5):317-34. doi: 10.1002/wsbm.1308. Epub 2015 Jun 24. Review.

23.

Natural killer T (NKT) cells accelerate Shiga toxin type 2 (Stx2) pathology in mice.

Obata F, Subrahmanyam PB, Vozenilek AE, Hippler LM, Jeffers T, Tongsuk M, Tiper I, Saha P, Jandhyala DM, Kolling GL, Latinovic O, Webb TJ.

Front Microbiol. 2015 Apr 8;6:262. doi: 10.3389/fmicb.2015.00262. eCollection 2015.

24.

Zinc deficiency alters host response and pathogen virulence in a mouse model of enteroaggregative Escherichia coli-induced diarrhea.

Bolick DT, Kolling GL, Moore JH 2nd, de Oliveira LA, Tung K, Philipson C, Viladomiu M, Hontecillas R, Bassaganya-Riera J, Guerrant RL.

Gut Microbes. 2014;5(5):618-27. doi: 10.4161/19490976.2014.969642.

25.

Role of leptin-mediated colonic inflammation in defense against Clostridium difficile colitis.

Madan R, Guo X, Naylor C, Buonomo EL, Mackay D, Noor Z, Concannon P, Scully KW, Pramoonjago P, Kolling GL, Warren CA, Duggal P, Petri WA Jr.

Infect Immun. 2014 Jan;82(1):341-9. doi: 10.1128/IAI.00972-13. Epub 2013 Oct 28.

26.

Proposal for effective treatment of Shiga toxin-producing Escherichia coli infection in mice.

Amran MY, Fujii J, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S.

Microb Pathog. 2013 Dec;65:57-62. doi: 10.1016/j.micpath.2013.09.008. Epub 2013 Oct 10.

PMID:
24120399
27.

The micronutrient zinc inhibits EAEC strain 042 adherence, biofilm formation, virulence gene expression, and epithelial cytokine responses benefiting the infected host.

Medeiros P, Bolick DT, Roche JK, Noronha F, Pinheiro C, Kolling GL, Lima A, Guerrant RL.

Virulence. 2013 Oct 1;4(7):624-33. doi: 10.4161/viru.26120. Epub 2013 Aug 19.

28.

In vivo physiological and transcriptional profiling reveals host responses to Clostridium difficile toxin A and toxin B.

D'Auria KM, Kolling GL, Donato GM, Warren CA, Gray MC, Hewlett EL, Papin JA.

Infect Immun. 2013 Oct;81(10):3814-24. doi: 10.1128/IAI.00869-13. Epub 2013 Jul 29.

29.

Investigation of encephalopathy caused by Shiga toxin 2c-producing Escherichia coli infection in mice.

Amran MY, Fujii J, Suzuki SO, Kolling GL, Villanueva SY, Kainuma M, Kobayashi H, Kameyama H, Yoshida S.

PLoS One. 2013;8(3):e58959. doi: 10.1371/journal.pone.0058959. Epub 2013 Mar 13.

30.

Intestinal epithelial restitution after TcdB challenge and recovery from Clostridium difficile infection in mice with alanyl-glutamine treatment.

Rodrigues RS, Oliveira RA, Li Y, Zaja-Milatovic S, Costa LB, Braga Neto MB, Kolling GL, Lima AA, Guerrant RL, Warren CA.

J Infect Dis. 2013 May 15;207(10):1505-15. doi: 10.1093/infdis/jit041. Epub 2013 Jan 28.

31.

Shiga toxin 2-induced intestinal pathology in infant rabbits is A-subunit dependent and responsive to the tyrosine kinase and potential ZAK inhibitor imatinib.

Stone SM, Thorpe CM, Ahluwalia A, Rogers AB, Obata F, Vozenilek A, Kolling GL, Kane AV, Magun BE, Jandhyala DM.

Front Cell Infect Microbiol. 2012 Nov 8;2:135. doi: 10.3389/fcimb.2012.00135. eCollection 2012.

32.

Vancomycin treatment's association with delayed intestinal tissue injury, clostridial overgrowth, and recurrence of Clostridium difficile infection in mice.

Warren CA, van Opstal EJ, Riggins MS, Li Y, Moore JH, Kolling GL, Guerrant RL, Hoffman PS.

Antimicrob Agents Chemother. 2013 Feb;57(2):689-96. doi: 10.1128/AAC.00877-12. Epub 2012 Nov 12.

33.

Lactic acid production by Streptococcus thermophilus alters Clostridium difficile infection and in vitro Toxin A production.

Kolling GL, Wu M, Warren CA, Durmaz E, Klaenhammer TR, Timko MP, Guerrant RL.

Gut Microbes. 2012 Nov-Dec;3(6):523-9. doi: 10.4161/gmic.21757. Epub 2012 Aug 16. Erratum in: Gut Microbes. 2013 Mar-Apr;4(2):175. Timko, Michael P [added].

34.

Amixicile, a novel inhibitor of pyruvate: ferredoxin oxidoreductase, shows efficacy against Clostridium difficile in a mouse infection model.

Warren CA, van Opstal E, Ballard TE, Kennedy A, Wang X, Riggins M, Olekhnovich I, Warthan M, Kolling GL, Guerrant RL, Macdonald TL, Hoffman PS.

Antimicrob Agents Chemother. 2012 Aug;56(8):4103-11. doi: 10.1128/AAC.00360-12. Epub 2012 May 14.

35.

Systems analysis of the transcriptional response of human ileocecal epithelial cells to Clostridium difficile toxins and effects on cell cycle control.

D'Auria KM, Donato GM, Gray MC, Kolling GL, Warren CA, Cave LM, Solga MD, Lannigan JA, Papin JA, Hewlett EL.

BMC Syst Biol. 2012 Jan 6;6:2. doi: 10.1186/1752-0509-6-2.

36.

Murine model of Clostridium difficile infection with aged gnotobiotic C57BL/6 mice and a BI/NAP1 strain.

Pawlowski SW, Calabrese G, Kolling GL, Platts-Mills J, Freire R, AlcantaraWarren C, Liu B, Sartor RB, Guerrant RL.

J Infect Dis. 2010 Dec 1;202(11):1708-12. doi: 10.1086/657086. Epub 2010 Oct 26. Erratum in: J Infect Dis. 2011 May 15;203(10):1505. Platts-Mills, J [added].

37.

Shiga toxin 2 targets the murine renal collecting duct epithelium.

Psotka MA, Obata F, Kolling GL, Gross LK, Saleem MA, Satchell SC, Mathieson PW, Obrig TG.

Infect Immun. 2009 Mar;77(3):959-69. doi: 10.1128/IAI.00679-08. Epub 2009 Jan 5.

38.

Shiga toxin 2 affects the central nervous system through receptor globotriaosylceramide localized to neurons.

Obata F, Tohyama K, Bonev AD, Kolling GL, Keepers TR, Gross LK, Nelson MT, Sato S, Obrig TG.

J Infect Dis. 2008 Nov 1;198(9):1398-406. doi: 10.1086/591911.

39.

Immunohistologic techniques for detecting the glycolipid Gb(3) in the mouse kidney and nervous system.

Kolling GL, Obata F, Gross LK, Obrig TG.

Histochem Cell Biol. 2008 Jul;130(1):157-64. doi: 10.1007/s00418-008-0417-8. Epub 2008 Mar 26.

PMID:
18365234
42.
43.

Examination of recovery in vitro and in vivo of nonculturable Escherichia coli O157:H7.

Kolling GL, Matthews KR.

Appl Environ Microbiol. 2001 Sep;67(9):3928-33.

44.

Vesicle-mediated transfer of virulence genes from Escherichia coli O157:H7 to other enteric bacteria.

Yaron S, Kolling GL, Simon L, Matthews KR.

Appl Environ Microbiol. 2000 Oct;66(10):4414-20.

45.

Export of virulence genes and Shiga toxin by membrane vesicles of Escherichia coli O157:H7.

Kolling GL, Matthews KR.

Appl Environ Microbiol. 1999 May;65(5):1843-8.

Supplemental Content

Loading ...
Support Center